Physician profile
Peter J Bregman
NPI 1235165671
$17,699.89
in general payments reported to CMS, 2019-2025
35 companies · $2,644 in 2025
The $2,644 reported for 2025 was more than what 93% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,596 · 2020: $232 · 2021: $2,743 · 2022: $3,180 · 2023: $4,219 · 2024: $3,086 · 2025: $2,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $7,459 · Food and Beverage: $1,215 · Debt Forgiveness: $1,150 · Consulting Fee: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $7,458.65 |
| Food and Beverage | $1,214.86 |
| Debt Forgiveness | $1,150.00 |
| Consulting Fee | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $9,826.56 | 2022-2025 | Motoband |
| Crossroads Extremity Systems, LLC | $1,983.46 | 2021 | |
| Smith+Nephew, INC. | $1,192.14 | 2020-2023 | Grafix Pl |
| Biotissue Holdings INC. | $724.44 | 2021-2023 | |
| Wright Medical Technology, INC. | $695.71 | 2019 | |
| Stimwave Technologies Incorporated | $479.05 | 2019 | |
| Nalu Medical, INC. | $429.58 | 2021-2025 | Nalu Neurostimulation System |
| Cpm Medical Consultants, LLC | $379.22 | 2019-2021 | |
| Abbvie INC. | $230.52 | 2022 | |
| Anika Therapeutics, INC. | $219.29 | 2022-2023 | Lesser, Parcus Suture Anchors, Toe Motion |
| Mimedx Group, INC. | $217.07 | 2024-2025 | |
| Flower Orthopedics Coporation | $142.31 | 2019 | |
| Stryker Corporation | $139.91 | 2021-2024 | Salvation |
| Next Science LLC | $130.42 | 2020 | |
| Bioventus LLC | $108.41 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $91.57 | 2022-2024 | Nuzyra |
| Nevro Corp. | $80.61 | 2024 | Senza |
| Averitas Pharma INC. | $78.58 | 2023 | Qutenza |
| Zyla Life Sciences, INC. | $71.65 | 2019-2020 | |
| Tactile Systems Technology INC | $66.46 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $65.48 | 2022-2023 | Seglentis |
| Axogen | $53.28 | 2022-2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Voom Medical Devices, INC. | $34.42 | 2024 | Revcon |
| Orthofix Medical, INC. | $30.25 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $29.32 | 2019 | |
| Linvatec Corporation | $24.82 | 2024 | Hall Power |
| Globus Medical, INC. | $24.35 | 2025 | Senza |
| Lifenet Health | $24.28 | 2023 | |
| Kerecis Limited | $22.78 | 2021 | |
| Melinta Therapeutics, LLC | $21.86 | 2019 | |
| Alfasigma USA, INC. | $21.17 | 2022 | |
| Innovation Technologies INC | $18.29 | 2022 | |
| Maruho Medical, INC. | $17.86 | 2020 | |
| Abbott Laboratories | $14.89 | 2023 | Proclaim |
| Cardiovascular Systems INC. | $9.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bregman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.